SCHEMBL2359280

SCHEMBL2359280

C=CC(=O)OCC(COCCCCC)OC(=O)C=C

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.55
HPGD P15428 1/20 0.53
ALDH1A1 P00352 4/20 0.44
CYP3A4 P08684 1/20 0.44
LMNA P02545 1/20 0.43
PLA2G2C Q5R387 1/20 0.43
TP53 P04637 2/20 0.41
HIF1A Q16665 2/20 0.41
HSD17B10 Q99714 1/20 0.41
AKT1 P31749 2/20 0.39
AKT2 P31751 2/20 0.39
AKT3 Q9Y243 2/20 0.39
PIK3R1 P27986 1/20 0.39
PIK3CA P42336 1/20 0.39
LPAR1 Q92633 2/20 0.39
LPAR3 Q9UBY5 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18116400 0.96 TSHR (0.51) TSHRHPGDALDH1A1CYP3A4LMNA
SCHEMBL14824448 0.95 TSHR (0.59) TSHRHPGDALDH1A1CYP3A4LMNA
SCHEMBL14828464 0.91 TSHR (0.54) TSHRHPGDALDH1A1CYP3A4LMNA
SCHEMBL28531918 0.89 TSHR (0.59) TSHRHPGDALDH1A1CYP3A4LMNA
SCHEMBL28907629 0.89 TSHR (0.59) TSHRHPGDALDH1A1CYP3A4LMNA
SCHEMBL28907626 0.89 TSHR (0.59) TSHRHPGDALDH1A1CYP3A4LMNA
SCHEMBL28532330 0.89 TSHR (0.59) TSHRHPGDALDH1A1CYP3A4LMNA
SCHEMBL30690805 0.89 TSHR (0.50) TSHRHPGDALDH1A1CYP3A4LMNA
SCHEMBL28632421 0.88 TSHR (0.71) TSHRHPGDALDH1A1CYP3A4LMNA
SCHEMBL28763654 0.86 ALDH1A1 (0.52) TSHRHPGDALDH1A1CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9441065-B2 Curable composition for imprints, cured product and method for manufacturing a cured product FUJIFILM CORPORATION (JP) 2016-09-13 US disclosed
US-8999221-B2 Curable composition for imprints, patterning method and pattern FUJIFILM CORPORATION (JP) 2015-04-07 US disclosed
US-8883065-B2 Curable composition for imprints, patterning method and pattern FUJIFILM CORPORATION (JP) 2014-11-11 US disclosed
US-20140121292-A1 CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN FUJIFILM CORPORATION (JP) 2014-05-01 US disclosed
US-20110236595-A1 CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN FUJIFILM CORPORATION (JP) 2011-09-29 US disclosed
EP-2352768-A2 CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN FUJIFILM Corporation (JP) 2011-08-10 EP disclosed
WO-2010064726-A2 CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN FUJIFILM CORPORATION (JP) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110236595-A1 CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN DNMT3L, DNMT3A, DNMT1 TSHR 4211/4885HPGD 4554/4885ALDH1A1 2439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.